These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29470533)

  • 1. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
    Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
    PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
    Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
    Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
    MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.
    Mousa JJ; Sauer MF; Sevy AM; Finn JA; Bates JT; Alvarado G; King HG; Loerinc LB; Fong RH; Doranz BJ; Correia BE; Kalyuzhniy O; Wen X; Jardetzky TS; Schief WR; Ohi MD; Meiler J; Crowe JE
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6849-E6858. PubMed ID: 27791117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
    Huang J; Miller RJ; Mousa JJ
    Front Immunol; 2022; 13():941865. PubMed ID: 36003370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
    Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
    Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
    Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
    PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
    Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
    Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
    Mousa JJ; Kose N; Matta P; Gilchuk P; Crowe JE
    Nat Microbiol; 2017 Jan; 2():16271. PubMed ID: 28134924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody recognition of the Pneumovirus fusion protein trimer interface.
    Huang J; Diaz D; Mousa JJ
    PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
    Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
    Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode.
    Wen X; Suryadevara N; Kose N; Liu J; Zhan X; Handal LS; Williamson LE; Trivette A; Carnahan RH; Jardetzky TS; Crowe JE
    Cell Host Microbe; 2023 Aug; 31(8):1288-1300.e6. PubMed ID: 37516111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Epitopes of Pneumovirus Fusion Proteins.
    Huang J; Diaz D; Mousa JJ
    Front Immunol; 2019; 10():2778. PubMed ID: 31849961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F.
    McLellan JS; Chen M; Chang JS; Yang Y; Kim A; Graham BS; Kwong PD
    J Virol; 2010 Dec; 84(23):12236-44. PubMed ID: 20881049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV.
    Wen X; Pickens J; Mousa JJ; Leser GP; Lamb RA; Crowe JE; Jardetzky TS
    PLoS One; 2016; 11(5):e0155917. PubMed ID: 27224013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.
    Blais N; Gagné M; Hamuro Y; Rheault P; Boyer M; Steff AM; Baudoux G; Dewar V; Demers J; Ruelle JL; Martin D
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28404847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
    Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
    J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
    Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.